Q4 EPS Forecast for Core Laboratories Decreased by Analyst

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research dropped their Q4 2026 earnings per share estimates for Core Laboratories in a report issued on Wednesday, May 14th. Zacks Research analyst R. Department now anticipates that the oil and gas company will post earnings per share of $0.28 for the quarter, down from their prior estimate of $0.34. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share.

CLB has been the subject of a number of other research reports. Citigroup dropped their price target on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating for the company in a research note on Tuesday, May 13th. Stifel Nicolaus reduced their price target on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a research report on Tuesday, April 15th. Finally, StockNews.com cut Core Laboratories from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $15.00.

Core Laboratories Stock Up 0.2%

NYSE CLB opened at $11.89 on Monday. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The company has a market cap of $557.35 million, a price-to-earnings ratio of 18.01, a PEG ratio of 0.99 and a beta of 1.45. The company has a 50 day moving average of $13.01 and a 200-day moving average of $16.44. Core Laboratories has a 1-year low of $10.14 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm’s revenue was down 4.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.19 earnings per share.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories’s dividend payout ratio is 6.78%.

Institutional Trading of Core Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Franklin Resources Inc. bought a new stake in Core Laboratories during the 4th quarter worth $464,000. Amundi increased its stake in shares of Core Laboratories by 194.8% in the fourth quarter. Amundi now owns 32,968 shares of the oil and gas company’s stock valued at $600,000 after buying an additional 21,783 shares during the period. Boston Trust Walden Corp raised its holdings in Core Laboratories by 2.7% in the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock valued at $10,686,000 after buying an additional 16,503 shares during the last quarter. Principal Financial Group Inc. boosted its position in Core Laboratories by 3.1% during the 4th quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company’s stock worth $3,966,000 after buying an additional 6,827 shares during the period. Finally, Norges Bank bought a new stake in Core Laboratories during the 4th quarter worth approximately $1,910,000. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.